Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SAGE 1-Step is a continuous, single-step culture medium developed by CooperSurgical (under the SAGE brand) for the in vitro development of human embryos. It is designed to support embryo growth from the zygote stage through to the blastocyst stage (Day 5-7) without the need for sequential media changes. This "one-step" approach aims to maintain a stable environment, minimizing fluctuations in pH and temperature and reducing the mechanical stress associated with embryo handling. The medium is typically supplemented with Human Albumin Solution (HAS) to provide necessary proteins. In clinical trials, such as those sponsored by the European Hospital, SAGE 1-Step has been compared to sequential media systems to evaluate its impact on clinical pregnancy rates and embryo quality, particularly in patients with poor prognosis or severe male infertility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SAGE 1-Step.